Related Experiment Video

Updated: Oct 3, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K

Therapeutic potential of miRNAs in Clostridioides difficile infection

Tanya M Monaghan1,2, Christos Polytarchou3,4, Dina Kao5

  • 1National Institute for Health Research Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, NG7 2UH, UK.

Future Microbiology
|February 17, 2022
PubMed

Insights

MicroRNAs (miRNAs) combined with live biotherapeutic products show promise for treating Clostridioides difficile infection. This approach may enhance treatment effectiveness and combat antibiotic resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Clostridioides difficile infection (CDI) poses a significant healthcare challenge due to rising antibiotic resistance.
  • Current treatments for CDI have limitations, including recurrence and the emergence of resistant strains.

Discussion:

  • MicroRNAs (miRNAs) are investigated as a novel therapeutic strategy for infectious diseases.
  • The combination of miRNAs with live biotherapeutic products (LBPs) is explored to enhance treatment outcomes for CDI.

Key Insights:

  • miRNAs, alone or in combination with LBPs, demonstrate potential to augment the therapeutic efficacy against C. difficile.
  • This combined approach may offer a strategy to counteract drug resistance associated with CDI treatments.

Outlook:

  • Further research into miRNA-based therapies could lead to innovative treatments for CDI.
  • The development of combination therapies involving miRNAs and LBPs holds promise for future clinical applications in combating antibiotic-resistant infections.
Keywords:
Clostridioides difficile infectionRNA therapeuticsmiRNA-based drugsmiRNAsnanocarriers

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
446